Atopy is a Risk Factor for Respiratory Symptoms in COPD Patients: Results from the EUROSCOP Study

Overview

Journal Respir Res

Specialty Pulmonary Medicine

Date 2013 Jan 30

PMID 23356508

Citations 20

Authors

Fatemeh Fattahi

Nick H T Ten Hacken

Claes-Goran Lofdahl

Machteld N Hylkema

Wim Timens

Dirkje S Postma

Judith M Vonk

Affiliations

Soon will be listed here.

Abstract

Background: The pathogenesis of COPD is complex and remains poorly understood. The European Respiratory Society Study on Chronic Obstructive Pulmonary Disease (EUROSCOP) investigated long-term effects of budesonide; 18% of the COPD participants were atopic. So far effects of atopy on the long-term course of COPD have not been elucidated.

Methods: Factors related to the presence of atopy (positive phadiatop) in 1277 mild-to-moderate COPD patients participating in EUROSCOP were analysed using regression analysis. Incidence and remission of respiratory symptoms during 3-year follow-up were analysed using generalised estimating equations models, and association of atopy with lung function decline using linear mixed effects models.

Results: Independent predisposing factors associated with the presence of atopy were: male gender (OR: 2.21; 95% CI: 1.47-3.34), overweight/obese (OR: 1.41; 95% CI: 1.04-1.92) and lower age (OR: 0.98; 95% CI: 0.96-0.99). Atopy was associated with a higher prevalence of cough (OR: 1.71; 95% CI: 1.26-2.34) and phlegm (OR: 1.50; 95% CI: 1.10-2.03), but not with lung function levels or FEV1 decline. Atopic COPD patients not treated with budesonide had an increased incidence of cough over time (OR: 1.79, 95% CI: 1.03-3.08, p = 0.038), while those treated with budesonide had increased remission of cough (OR: 1.93, 95% CI: 1.11-3.37, p = 0.02) compared to non-atopic COPD patients.

Conclusions: Atopic COPD patients are more likely male, have overweight/obesity and are younger as compared with non-atopic COPD patients. Atopy in COPD is associated with an increased incidence and prevalence of respiratory symptoms. If atopic COPD patients are treated with budesonide, they more often show remission of symptoms compared to non-atopic COPD patients who are treated with budesonide. We recommend including atopy in the diagnostic work-up and management of COPD.

Citing Articles

Factors Associated with Chronic Obstructive Pulmonary Disease: A Hospital-Based Case-Control Study.

Twinamasiko B, Mutekanga A, Ogueri O, Kisakye N, North C, Muzoora C Int J Chron Obstruct Pulmon Dis. 2023; 18:2521-2529.

PMID: 38022824 PMC: 10644879. DOI: 10.2147/COPD.S426928.

From Biomarkers to Novel Therapeutic Approaches in Chronic Obstructive Pulmonary Disease.

Wang H, Cheng S Biomedicines. 2021; 9(11).

PMID: 34829866 PMC: 8615492. DOI: 10.3390/biomedicines9111638.

Home Dust Allergen Exposure Is Associated with Outcomes among Sensitized Individuals with Chronic Obstructive Pulmonary Disease.

Putcha N, Woo H, McCormack M, Fawzy A, Romero K, Davis M Am J Respir Crit Care Med. 2021; 205(4):412-420.

PMID: 34752729 PMC: 8886951. DOI: 10.1164/rccm.202103-0583OC.

The Role of Atopy in COPD and Asthma.

Karakioulaki M, Papakonstantinou E, Goulas A, Stolz D Front Med (Lausanne). 2021; 8:674742.

PMID: 34490286 PMC: 8418108. DOI: 10.3389/fmed.2021.674742.

Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs.

Matsunaga K, Harada M, Suizu J, Oishi K, Asami-Noyama M, Hirano T J Clin Med. 2020; 9(10).

PMID: 32987778 PMC: 7598716. DOI: 10.3390/jcm9103078.

References

Govaere E, Van Gysel D, Massa G, Verhamme K, Doli E, De Baets F . The influence of age and gender on sensitization to aero-allergens. Pediatr Allergy Immunol. 2007; 18(8):671-8. DOI: 10.1111/j.1399-3038.2007.00570.x. View

Sears M, Burrows B, Flannery E, Herbison G, Holdaway M . Atopy in childhood. I. Gender and allergen related risks for development of hay fever and asthma. Clin Exp Allergy. 1993; 23(11):941-8. DOI: 10.1111/j.1365-2222.1993.tb00279.x. View

Jamieson D, Matsui E, Belli A, McCormack M, Peng E, Pierre-Louis S . Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013; 188(2):187-92. PMC: 3778754. DOI: 10.1164/rccm.201211-2103OC. View

Pavord I, Brightling C, Woltmann G, Wardlaw A . Non-eosinophilic corticosteroid unresponsive asthma. Lancet. 1999; 353(9171):2213-4. DOI: 10.1016/S0140-6736(99)01813-9. View

BARBEE R, Brown W, Kaltenborn W, Halonen M . Allergen skin-test reactivity in a community population sample: correlation with age, histamine skin reactions and total serum immunoglobulin E. J Allergy Clin Immunol. 1981; 68(1):15-9. DOI: 10.1016/0091-6749(81)90117-2. View

Platts-Mills T, Erwin E, Heymann P, Woodfolk J . Is the hygiene hypothesis still a viable explanation for the increased prevalence of asthma?. Allergy. 2005; 60 Suppl 79:25-31. DOI: 10.1111/j.1398-9995.2005.00854.x. View

Pauwels R, Lofdahl C, Laitinen L, Schouten J, Postma D, Pride N . Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med. 1999; 340(25):1948-53. DOI: 10.1056/NEJM199906243402503. View

BARBEE R, Halonen M, Kaltenborn W, Lebowitz M, Burrows B . A longitudinal study of serum IgE in a community cohort: correlations with age, sex, smoking, and atopic status. J Allergy Clin Immunol. 1987; 79(6):919-27. DOI: 10.1016/0091-6749(87)90241-7. View

Sherrill D, LEBOWITZ M, Halonen M, BARBEE R, Burrows B . Longitudinal evaluation of the association between pulmonary function and total serum IgE. Am J Respir Crit Care Med. 1995; 152(1):98-102. DOI: 10.1164/ajrccm.152.1.7599870. View

10.

Sahn S . Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest. 1978; 73(3):389-96. DOI: 10.1378/chest.73.3.389. View

11.

Tracey M, Villar A, Dow L, Coggon D, Lampe F, Holgate S . The influence of increased bronchial responsiveness, atopy, and serum IgE on decline in FEV1. A longitudinal study in the elderly. Am J Respir Crit Care Med. 1995; 151(3 Pt 1):656-62. DOI: 10.1164/ajrccm/151.3_Pt_1.656. View

12.

Miravitlles M . Cough and sputum production as risk factors for poor outcomes in patients with COPD. Respir Med. 2011; 105(8):1118-28. DOI: 10.1016/j.rmed.2011.02.003. View

13.

Watson L, Schouten J, Lofdahl C, Pride N, Laitinen L, Postma D . Predictors of COPD symptoms: does the sex of the patient matter?. Eur Respir J. 2006; 28(2):311-8. DOI: 10.1183/09031936.06.00055805. View

14.

Watson L, Vonk J, Lofdahl C, Pride N, Pauwels R, Laitinen L . Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study. Respir Med. 2005; 100(4):746-53. DOI: 10.1016/j.rmed.2005.08.004. View

15.

Siroux V, Curt F, Oryszczyn M, Maccario J, Kauffmann F . Role of gender and hormone-related events on IgE, atopy, and eosinophils in the Epidemiological Study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy. J Allergy Clin Immunol. 2004; 114(3):491-8. DOI: 10.1016/j.jaci.2004.05.027. View

16.

Sutherland T, Cowan J, Young S, Goulding A, Grant A, Williamson A . The association between obesity and asthma: interactions between systemic and airway inflammation. Am J Respir Crit Care Med. 2008; 178(5):469-75. DOI: 10.1164/rccm.200802-301OC. View

17.

Kay A . Overview of 'allergy and allergic diseases: with a view to the future'. Br Med Bull. 2001; 56(4):843-64. DOI: 10.1258/0007142001903481. View

18.

Gottlieb D, Sparrow D, OConnor G, Weiss S . Skin test reactivity to common aeroallergens and decline of lung function. The Normative Aging Study. Am J Respir Crit Care Med. 1996; 153(2):561-6. DOI: 10.1164/ajrccm.153.2.8564098. View

19.

Jansen D, Rijcken B, Schouten J, Kraan J, Weiss S, Timens W . The relationship of skin test positivity, high serum total IgE levels, and peripheral blood eosinophilia to symptomatic and asymptomatic airway hyperresponsiveness. Am J Respir Crit Care Med. 1999; 159(3):924-31. DOI: 10.1164/ajrccm.159.3.9804024. View

20.

Kauffmann F, Neukirch F, Korobaeff M, Marne M, Claude J, Lellouch J . Eosinophils, smoking, and lung function. An epidemiologic survey among 912 working men. Am Rev Respir Dis. 1986; 134(6):1172-5. DOI: 10.1164/arrd.1986.134.6.1172. View